WVE Stock Analysis: Buy, Sell, or Hold?
WVE - Wave Life Sciences Ltd. Ordinary Shares
$6.90
-0.09 (-1.29%)
▼
5d:
-4.7%
30d:
-9.09%
90d:
-46.09%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Smart Money Accumulation
WVE is down 4.7% this week, but smart money is accumulating calls. Top strike: $8 2026-06-18 with 11,391 OI. Call ratio: 92% View Scanner →
Strength: 6.5/10
Get Alerted When WVE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: WVE shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: WVE shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: WVE is currently trading at $6.90, which is considered oversold relative to its 30-day fair value range of $7.02 to $7.42.
Technical Outlook: Technically, WVE is in a strong downtrend. The price is currently testing key support at $6.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $22.56 (+227.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, WVE is in a strong downtrend. The price is currently testing key support at $6.75. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $22.56 (+227.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.02 -
$7.42
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 227.0% below Wall St target ($22.56)
Trading Range Analysis
30-Day Trading Range
$7.02 -
$7.42
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.75
Resistance Level
$7.62
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.23
Wall Street Target
$22.56
(+227.0%)
Revenue Growth (YoY)
316.9%
Profit Margin
-255.7%
Share & Embed Analysis
Last updated: May 15, 2026 2:42 AM ET
Data refreshes hourly during market hours. Next update: 3:42 AM
Data refreshes hourly during market hours. Next update: 3:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WVE showing a specific setup today?
Insider Activity (6 Months)
1
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Chris Francis
SELL
33194 shares
2026-02-26
Chandra Vargeese
SELL
3228 shares
2026-02-09
Chris Francis
SELL
1883 shares
2026-02-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$411 | 60 BUY |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 50 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 59 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$109 | 65 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$84 | 55 HOLD |
Advanced WVE Option Strategies
Professional options setups generated by AI based on today's WVE price and gamma walls.
